References
- O’Neil ME, Mack KA, Gilchrist J, et al. Snakebite injuries treated in United States emergency departments, 2001–2004. Wilderness Environ Med. 2007;18:281–287.
- Curry SC, Horning D, Brady P, et al. The legitimacy of rattlesnake bites in central Arizona. Ann Emerg Med. 1989;18:658–663.
- Tanen DA, Ruha AM, Graeme KA, et al. Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary care referral center in central Arizona. Acad Emerg Med. 2001;8:177–182.
- Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;12:2002–2012.
- Ruha AM, Kleinschmidt K, Greene S, on behalf of the ToxIC Snakebite Study Group, et al. The epidemiologic and clinical characteristics of snakebites in the North American Snakebite Registry. J Med Toxicol. 2017. Forthcoming.
- Ruha AM, Curry SC, Albrecht C, et al. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom. Toxicon. 2011;57:53–59.
- Ruha AM, Curry SC, Beuhler M, et al. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002;39:609–615.
- Levine M, Ruha AM, Padilla-Jones A, et al. Bleeding following rattlesnake envenomation in patients with preenvenomation use of antiplatelet or anticoagulant medications. Acad Emerg Med. 2014;21:301–307.
- Seifert SA, Kirschner RI, Martin N. Recurrent, persistent, or late, new-onset hematologic abnormalities in Crotaline snake bite. Clin Toxicol. 2011;49:324–329.
- Lavonas EJ, Kahtri V, Daugherty C, et al. Medically significant late bleeding after treated Crotaline envenomation: a systematic review. Ann Emerg Med. 2014;63:71–78.
- Heise CW, Ruha AM, Hayek CT, et al. Predictors of tissue necrosis following upper extremity rattlesnake envenomation [abstract]. J Med Toxicol 2016;12:30.